# Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

Study · id `cardio:ct-nct06711003` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06711003](<https://clinicaltrials.gov/study/NCT06711003>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06711003

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

## Technical summary

Registry record NCT06711003. Non-randomized; no masking; primary purpose treatment. Start 2024-10-22 (actual); primary completion 2025-05-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT06711003, source copy `cardio:ctgov-nct06711003-2024-12-02`, retrieved 2026-10-26)
- Started: 2024-10-22 (actual) (ClinicalTrials.gov record NCT06711003, source copy `cardio:ctgov-nct06711003-2024-12-02`, retrieved 2026-10-26)
- Primary completion: 2025-05-15 (anticipated) (ClinicalTrials.gov record NCT06711003, source copy `cardio:ctgov-nct06711003-2024-12-02`, retrieved 2026-10-26)
- Completion: 2025-05-15 (anticipated) (ClinicalTrials.gov record NCT06711003, source copy `cardio:ctgov-nct06711003-2024-12-02`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT06711003, source copy `cardio:ctgov-nct06711003-2024-12-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06711003-2024-12-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
- Condition: Cerebrovascular Accident (CVA)
- Intervention (Device): enhanced external counterpulsation
- Intervention (Procedure): post acute care
- Lead sponsor: China Medical University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: China Medical University Hospital (`cardio:org-china-medical-university-hospital`)

## Provenance

Content hash: 3d3b3084e523846a7ebda01c23a3158425cd5fb3b3f093c3eaae537c7c6a136f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
